(Mark One) |
||
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|

(State or other jurisdiction
of incorporation or organization)
|
(IRS Employer Identification Number) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
||
☒ |
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
Smaller reporting
company
|
Emerging growth
company
|
Period |
Total Number
of Shares
Purchased(1)
|
Average Price
Paid Per Share
|
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
|
Average Price
Paid Per Share
|
Maximum Number of
Shares that May Yet Be
Purchased Under
Outstanding Plans or
Programs(2)
|
|||||
October 1-31, 2025 . . . . . . . . . . .
|
200,499 |
$238.98 |
200,499 |
$238.98 |
3,150,971 |
|||||
November 1-30, 2025 . . . . . . . . .
|
790,725 |
257.88 |
790,725 |
257.88 |
2,360,246 |
|||||
December 1-31, 2025 . . . . . . . . .
|
357,293 |
274.76 |
357,293 |
274.76 |
2,002,953 |
|||||
Total . . . . . . . . . . . . . . . . . . . . .
|
1,348,517 |
$259.54 |
1,348,517 |
$259.54 |

As of and for the Years Ended December 31, |
||||||||||
(in billions, except as noted) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Assets under management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$672.7 |
$707.9 |
5% |
$813.3 |
15% |
|||||
Average assets under management . . . . . . . . . . . . . . . . . . . . . . . . .
|
660.3 |
700.5 |
6% |
764.2 |
9% |
|||||
Aggregate fees (in millions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
5,066.6 |
5,236.0 |
3% |
6,167.5 |
18% |
|||||
Alternatives |
Differentiated Long-Only |
|||||||||
(in billions) |
Private
Markets
|
Liquid
Alternatives
|
Equities |
Multi-Asset &
Fixed Income
|
Total |
|||||
December 31, 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$135.4 |
$140.7 |
$316.2 |
$115.6 |
$707.9 |
|||||
Client cash inflows and commitments . . . . . . . . . . . .
|
24.1 |
73.6 |
42.5 |
20.7 |
160.9 |
|||||
Client cash outflows . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(0.2) |
(23.1) |
(87.8) |
(21.1) |
(132.2) |
|||||
Net client cash flows . . . . . . . . . . . . . . . . . . . . . . .
|
23.9 |
50.5 |
(45.3) |
(0.4) |
28.7 |
|||||
New investments(1) . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
10.6 |
12.4 |
— |
— |
23.0 |
|||||
Affiliate transactions(2) . . . . . . . . . . . . . . . . . . . . . . . .
|
(20.4) |
(0.0) |
(11.4) |
(0.7) |
(32.5) |
|||||
Market changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
2.3 |
21.4 |
48.8 |
12.8 |
85.3 |
|||||
Foreign exchange(3) . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
1.0 |
3.7 |
5.8 |
1.4 |
11.9 |
|||||
Realizations and distributions (net) . . . . . . . . . . . . . .
|
(5.4) |
(0.4) |
(2.0) |
(0.4) |
(8.2) |
|||||
Other(4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(1.4) |
(1.1) |
(0.0) |
(0.3) |
(2.8) |
|||||
December 31, 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$146.0 |
$227.2 |
$312.1 |
$128.0 |
$813.3 |
|||||
AUM Weight |
% of AUM Ahead of Benchmark(1)
|
|||||
IRR Latest Vintage |
IRR Last Three Vintages |
|||||
Private markets(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
18% |
86% |
86% |
|||
AUM Weight |
% of AUM Ahead of Benchmark(1)
|
|||||||
3-year |
5-year |
10-year |
||||||
Liquid alternatives(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
28% |
93% |
97% |
90% |
||||
Equities(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
38% |
38% |
44% |
55% |
||||
Multi-asset and fixed income(4) . . . . . . . . . . . . . . . . . . . . . . . .
|
16% |
N/A |
N/A |
N/A |
||||
For the Years Ended December 31, |
||||||||||
(in millions) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$906.1 |
$740.6 |
(18)% |
$904.0 |
22% |
|||||
Net income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . .
|
672.9 |
511.6 |
(24)% |
716.6 |
40% |
|||||
Adjusted EBITDA (controlling interest)(1) . . . . . . . . . . . . . . . . . . .
|
935.7 |
973.1 |
4% |
1,076.8 |
11% |
|||||
Economic net income (controlling interest)(1) . . . . . . . . . . . . . . . . .
|
717.8 |
701.6 |
(2)% |
769.3 |
10% |
|||||
For the Years Ended December 31, |
||||||||||
(in millions, except as noted) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Consolidated Affiliate average assets under management (in
billions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$393.7 |
$399.3 |
1% |
$411.0 |
3% |
|||||
Consolidated revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$2,057.8 |
$2,040.9 |
(1)% |
$ |
2% |
|||||
For the Years Ended December 31, |
||||||||||
(in millions) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Compensation and related expenses . . . . . . . . . . . . . . . . . . . . . . . .
|
$907.5 |
$915.3 |
1% |
$1,019.8 |
11% |
|||||
Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . .
|
358.2 |
376.5 |
5% |
408.6 |
9% |
|||||
Intangible amortization and impairments . . . . . . . . . . . . . . . . . . . .
|
48.3 |
29.0 |
(40)% |
160.3 |
N.M.(1)
|
|||||
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
123.8 |
133.3 |
8% |
136.5 |
2% |
|||||
Depreciation and other amortization . . . . . . . . . . . . . . . . . . . . . . .
|
13.0 |
13.4 |
3% |
10.4 |
(22)% |
|||||
Other expenses (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
45.8 |
40.3 |
(12)% |
69.8 |
73% |
|||||
Total consolidated expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$1,496.6 |
$1,507.8 |
1% |
$1,805.4 |
20% |
|||||
For the Years Ended December 31, |
||||||||||
(in millions, except as noted) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Operating Performance Measures |
||||||||||
Equity method Affiliate average assets under management (in
billions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$266.6 |
$301.2 |
13% |
$353.2 |
17% |
|||||
Equity method revenue, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$3,008.8 |
$3,195.1 |
6% |
$4,093.1 |
28% |
|||||
Financial Performance Measures |
||||||||||
Pre-tax equity method earnings . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$382.5 |
$455.7 |
19% |
$578.1 |
27% |
|||||
Equity method intangible amortization . . . . . . . . . . . . . . . . . . . . .
|
(86.0) |
(90.1) |
5% |
(98.1) |
9% |
|||||
Equity method intangible impairments . . . . . . . . . . . . . . . . . . . . . .
|
(9.6) |
(39.9) |
N.M.(1)
|
— |
N.M.(1)
|
|||||
Equity method income tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(6.9) |
(13.0) |
88% |
(17.1) |
32% |
|||||
Equity method income (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$280.0 |
$312.7 |
12% |
$462.9 |
48% |
|||||
For the Years Ended December 31, |
||||||||||
(in millions) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Affiliate transaction gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$133.1 |
$— |
N.M.(1)
|
$371.3 |
N.M.(1)
|
|||||
For the Years Ended December 31, |
||||||||||
(in millions) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Investment and other income . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$117.1 |
$77.4 |
(34)% |
$83.1 |
7% |
|||||
For the Years Ended December 31, |
||||||||||
(in millions) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$185.3 |
$182.6 |
(1)% |
$282.3 |
55% |
|||||
For the Years Ended December 31, |
||||||||||
(in millions) |
2023 |
2024 |
% Change |
2025 |
% Change |
|||||
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$906.1 |
$740.6 |
(18)% |
$904.0 |
22% |
|||||
Net income (non-controlling interests) . . . . . . . . . . . . . . . . . . . . . .
|
233.2 |
229.0 |
(2)% |
187.4 |
(18)% |
|||||
Net income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . .
|
672.9 |
511.6 |
(24)% |
716.6 |
40% |
|||||
For the Years Ended December 31, |
||||||
(in millions) |
2023 |
2024 |
2025 |
|||
Net income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$672.9 |
$511.6 |
$716.6 |
|||
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
123.8 |
133.3 |
136.3 |
|||
Income taxes(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
185.2 |
187.9 |
289.3 |
|||
Intangible amortization and impairments(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
128.5 |
149.2 |
214.4 |
|||
Affiliate transactions(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(162.7) |
— |
(377.5) |
|||
Other items(4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(12.0) |
(8.9) |
97.7 |
|||
Adjusted EBITDA (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$935.7 |
$973.1 |
$1,076.8 |
|||
For the Years Ended December 31, |
||||||
(in millions) |
2023 |
2024 |
2025 |
|||
Consolidated intangible amortization and impairments . . . . . . . . . . . . . . . . . . . . . . . . .
|
$48.3 |
$29.0 |
$160.3 |
|||
Consolidated intangible amortization and impairments (non-controlling interests) . . .
|
(15.4) |
(9.8) |
(44.0) |
|||
Equity method intangible amortization and impairments . . . . . . . . . . . . . . . . . . . . . . .
|
95.6 |
130.0 |
98.1 |
|||
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$128.5 |
$149.2 |
$214.4 |
|||
For the Years Ended December 31, |
||||||
(in millions, except per share data) |
2023 |
2024 |
2025 |
|||
Net income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$672.9 |
$511.6 |
$716.6 |
|||
Intangible amortization and impairments(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
128.5 |
149.2 |
214.4 |
|||
Intangible-related deferred taxes(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
57.3 |
61.9 |
45.1 |
|||
Affiliate transactions(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(122.1) |
— |
(284.4) |
|||
Other economic items(4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(18.8) |
(21.1) |
77.6 |
|||
Economic net income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$717.8 |
$701.6 |
$769.3 |
|||
Average shares outstanding (diluted) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
42.2 |
36.1 |
33.0 |
|||
Hypothetical issuance of shares to settle Redeemable non-controlling interests . . . . . . . .
|
(3.7) |
(1.6) |
(1.9) |
|||
Assumed issuance of junior convertible securities shares . . . . . . . . . . . . . . . . . . . . . . . . .
|
(1.7) |
(1.7) |
(1.7) |
|||
Dilutive impact of junior convertible securities shares . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
0.1 |
|||
Average shares outstanding (adjusted diluted) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
36.8 |
32.8 |
29.5 |
|||
Economic earnings per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$19.48 |
$21.36 |
$26.05 |
|||
For the Years Ended December 31, |
||||||
(in millions) |
2023 |
2024 |
2025 |
|||
Operating cash flow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$874.3 |
$932.1 |
$973.2 |
|||
Investing cash flow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
264.5 |
379.1 |
(206.1) |
|||
Financing cash flow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(758.3) |
(1,175.9) |
(1,148.7) |
|||
December 31, |
||||
(in millions) |
2024 |
2025 |
||
Senior bank debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$— |
$— |
||
Senior notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
1,097.4 |
1,172.0 |
||
Junior subordinated notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
1,216.0 |
1,216.1 |
||
Junior convertible securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
341.7 |
340.6 |
||
Total carrying value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
2,655.1 |
2,728.7 |
||
Debt issuance costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
(34.9) |
(37.4) |
||
Debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$2,620.2 |
$2,691.3 |
||
2030
Senior Notes
|
2034
Senior Notes
|
2036
Senior Notes
|
||||
Issue date . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
June 2020 |
August 2024 |
December 2025 |
|||
Maturity date . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
June 2030 |
August 2034 |
February 2036 |
|||
Par value (in millions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$350.0 |
$400.0 |
$425.0 |
|||
Stated coupon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
3.30% |
5.50% |
5.50% |
|||
Coupon frequency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
Semi-annually |
Semi-annually |
Semi-annually |
2059
Junior Subordinated
Notes
|
2060
Junior Subordinated
Notes
|
2061
Junior Subordinated
Notes
|
2064
Junior Subordinated
Notes
|
|||||
Issue date . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
March 2019 |
September 2020 |
July 2021 |
March 2024 |
||||
Maturity date . . . . . . . . . . . . . . . . . . . . . . . . .
|
March 2059 |
September 2060 |
September 2061 |
March 2064 |
||||
Par value (in millions) . . . . . . . . . . . . . . . . . .
|
$300.0 |
$275.0 |
$200.0 |
$450.0 |
||||
Stated coupon . . . . . . . . . . . . . . . . . . . . . . . . .
|
5.875% |
4.75% |
4.20% |
6.75% |
||||
Coupon frequency . . . . . . . . . . . . . . . . . . . . .
|
Quarterly |
Quarterly |
Quarterly |
Quarterly |
||||
NYSE Symbol . . . . . . . . . . . . . . . . . . . . . . . .
|
MGR |
MGRB |
MGRD |
MGRE |
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Consolidated revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Consolidated expenses: |
||||||
Compensation and related expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Intangible amortization and impairments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Depreciation and other amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Other expenses (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Total consolidated expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Equity method income (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Affiliate transaction gains (Notes 7 and 8) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Investment and other income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Income before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Net income (non-controlling interests) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Net income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Average shares outstanding (basic) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Average shares outstanding (diluted) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Earnings per share (basic) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Earnings per share (diluted) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Other comprehensive income, net of tax: |
||||||
Foreign currency translation gain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Change in net realized and unrealized gain (loss) on derivative financial instruments . .
|
( |
|||||
Change in net unrealized gain (loss) on available-for-sale debt securities . . . . . . . . . . .
|
||||||
Other comprehensive income, net of tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Comprehensive income (non-controlling interests) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Comprehensive income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
December 31, |
||||
2024 |
2025 |
|||
Assets |
||||
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Acquired client relationships (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Equity method investments in Affiliates (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Fixed assets (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Liabilities and Equity |
||||
Payables and accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Deferred tax liability (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Commitments and contingencies (Note 6) |
||||
Redeemable non-controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Equity: |
||||
Common stock ($
December 31, 2024 and 2025) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Less: Treasury stock, at cost ( |
( |
( |
||
Total stockholders' equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Non-controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Total equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Total liabilities and equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Total Stockholders’ Equity |
||||||||||||||
Common
Stock
|
Additional
Paid-In
Capital
|
Accumulated
Other
Comprehensive
Loss
|
Retained
Earnings
|
Treasury
Stock at
Cost
|
Non-
controlling
Interests
|
Total
Equity
|
||||||||
December 31, 2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$( |
$ |
$( |
$ |
$ |
|||||||
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
||||||||||
Other comprehensive income, net of tax . . . . . . . . . . . . . .
|
— |
— |
— |
— |
||||||||||
Share-based compensation . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
|||||||||
Common stock issued under share-based incentive plans .
|
— |
( |
— |
— |
— |
( |
||||||||
Share repurchases, inclusive of excise tax . . . . . . . . . . . . .
|
— |
— |
— |
( |
— |
( |
||||||||
Dividends ($ |
— |
— |
— |
( |
— |
— |
( |
|||||||
Affiliate equity-related activities: |
||||||||||||||
Affiliate equity expense . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
||||||||||
Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
( |
— |
— |
— |
|||||||||
Purchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
( |
|||||||||
Changes in redemption value of Redeemable non-
controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
( |
— |
— |
— |
— |
( |
|||||||
Transfers from Redeemable non-controlling interests . .
|
— |
— |
— |
— |
— |
|||||||||
Capital contributions and other . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
|||||||||
Distributions to non-controlling interests . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
( |
( |
|||||||
Effect of deconsolidation of Affiliates . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
( |
( |
||||||||
December 31, 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$( |
$ |
$( |
$ |
$ |
|||||||
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
||||||||||
Other comprehensive income (loss), net of tax . . . . . . . . .
|
— |
— |
— |
— |
( |
|||||||||
Share-based compensation . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
|||||||||
Common stock issued under share-based incentive plans .
|
— |
( |
— |
— |
( |
— |
( |
|||||||
Share repurchases, inclusive of excise tax . . . . . . . . . . . . .
|
— |
— |
— |
— |
( |
— |
( |
|||||||
Dividends ($ |
— |
— |
— |
( |
— |
— |
( |
|||||||
Affiliate equity-related activities: |
||||||||||||||
Affiliate equity expense . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
||||||||||
Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
( |
— |
— |
— |
|||||||||
Purchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
( |
— |
— |
— |
( |
( |
|||||||
Changes in redemption value of Redeemable non-
controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
( |
— |
— |
— |
— |
( |
|||||||
Transfers to Redeemable non-controlling interests . . . . .
|
— |
— |
— |
— |
— |
( |
( |
|||||||
Capital contributions and other . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
( |
( |
|||||||
Distributions to non-controlling interests . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
( |
( |
|||||||
December 31, 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$( |
$ |
$( |
$ |
$ |
|||||||
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
||||||||||
Other comprehensive income, net of tax . . . . . . . . . . . . . .
|
— |
— |
— |
— |
||||||||||
Share-based compensation . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
|||||||||
Common stock issued under share-based incentive plans .
|
— |
( |
— |
— |
( |
— |
( |
|||||||
Conversion premium on junior convertible securities, net
of tax (Note 5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
( |
— |
— |
— |
— |
( |
|||||||
Share repurchases, inclusive of excise tax . . . . . . . . . . . . .
|
— |
— |
— |
— |
( |
— |
( |
|||||||
Dividends ($ |
— |
— |
— |
( |
— |
— |
( |
|||||||
Affiliate equity-related activities: |
||||||||||||||
Affiliate equity expense . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
||||||||||
Issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
( |
— |
— |
— |
|||||||||
Purchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
( |
( |
||||||||
Changes in redemption value of Redeemable non-
controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
— |
( |
— |
— |
— |
— |
( |
|||||||
Transfers from Redeemable non-controlling interests . .
|
— |
— |
— |
— |
— |
|||||||||
Capital contributions and other . . . . . . . . . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
( |
( |
|||||||
Distributions to non-controlling interests . . . . . . . . . . . .
|
— |
— |
— |
— |
— |
( |
( |
|||||||
December 31, 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$( |
$ |
$( |
$ |
$ |
|||||||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Cash flow from (used in) operating activities: |
||||||
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Adjustments to reconcile Net income to cash flow from (used in) operating activities: |
||||||
Intangible amortization and impairments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Depreciation and other amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Deferred income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Equity method income (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Distributions received from equity method investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Affiliate transaction gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||||
Share-based compensation and Affiliate equity expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Net realized and unrealized gains on investment securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Other non-cash items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||||
Changes in assets and liabilities: |
||||||
Purchases of securities by consolidated Affiliate sponsored investment products . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Sales of securities by consolidated Affiliate sponsored investment products . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Increase in receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Decrease (increase) in other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||
(Decrease) increase in payables, accrued liabilities, and other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||||
Cash flow from operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Cash flow from (used in) investing activities: |
||||||
Investments in Affiliates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Proceeds from Affiliate transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Return of capital from equity method investments in Affiliates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Purchases of fixed assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Purchases of investment securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Maturities and sales of investment securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Cash flow from (used in) investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||
Cash flow from (used in) financing activities: |
||||||
Borrowings of senior bank debt, senior notes, and junior subordinated notes . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Repayments of senior bank debt, junior convertible securities, and senior notes . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Repurchases of common stock, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Dividends paid on common stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Distributions to non-controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Affiliate equity purchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Affiliate equity issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
(Redemptions) subscriptions to consolidated Affiliate sponsored investment products, net . . . . . . . . . . . . . . . .
|
( |
( |
||||
Settlement of deferred payments, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||||
Taxes paid on shares withheld on share-based awards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Other financing items . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Cash flow used in financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Effect of foreign currency exchange rate changes on cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||
Net increase (decrease) in cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||
Cash and cash equivalents at beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Effect of consolidation (deconsolidation) of Affiliates and Affiliate sponsored investment products . . . . . . . . . .
|
( |
|||||
Cash and cash equivalents at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Supplemental disclosure of cash flow information: |
||||||
Income taxes paid, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Interest paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Operating lease liabilities paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Supplemental disclosure of non-cash investing and financing activities: |
||||||
Shares received from Affiliate transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Conversion premium obligations on junior convertible securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Stock issued upon vesting of restricted stock units and exercise of stock options . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Payables recorded for Affiliate equity purchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Stock received for tax withholdings on share-based payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Stock received for the exercise of stock options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Payables recorded for investments in Affiliates and contingent payment obligations . . . . . . . . . . . . . . . . . . . . .
|
||||||
Right-of-use assets obtained in exchange for new operating leases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
December 31, |
||||
2024 |
2025 |
|||
Marketable securities |
||||
Equity securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Debt securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Total marketable securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Other investments |
||||
Investments measured at NAV as a practical expedient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Investments without readily determinable fair values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Total other investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
December 31, |
||||
2024 |
2025 |
|||
Cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Unrealized gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Unrealized losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
December 31, |
||||
2024 |
2025 |
|||
Cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Unrealized gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Unrealized losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
December 31, 2024 |
December 31, 2025 |
|||||||
Fair Value |
Unfunded
Commitments
|
Fair Value |
Unfunded
Commitments
|
|||||
Investments with limited liquidity(1) . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
Investments with periodic liquidity(2) . . . . . . . . . . . . . . . . . . .
|
||||||||
Total(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
December 31, |
||||
2024 |
2025 |
|||
Cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Cumulative unrealized gains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Carrying amount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
For the Years Ended December 31, |
||||||||||||
2024 |
2025 |
|||||||||||
Measured at
NAV as a
Practical
Expedient
|
Without
Readily
Determinable
Fair Values
|
Total |
Measured at
NAV as a
Practical
Expedient
|
Without
Readily
Determinable
Fair Values
|
Total |
|||||||
Balance, beginning of period . . . . . . .
|
$ |
$ |
$ |
$ |
$ |
$ |
||||||
Purchases and commitments funded(1)
|
||||||||||||
Sales and distributions . . . . . . . . . . . .
|
( |
( |
( |
( |
||||||||
Net realized and unrealized gains . . .
|
||||||||||||
Balance, end of period . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
$ |
$ |
||||||
Fair Value Measurements |
||||||||
December 31,
2024
|
||||||||
Level 1 |
Level 2 |
Level 3 |
||||||
Financial Assets(1)
|
||||||||
Investments in equity securities . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
Investments in debt securities . . . . . . . . . . . . . . . . . . . . . . .
|
||||||||
Financial Liabilities(2)
|
||||||||
Contingent payment obligations . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
Affiliate equity purchase obligations . . . . . . . . . . . . . . . . . .
|
||||||||
Fair Value Measurements |
||||||||
December 31,
2025
|
||||||||
Level 1 |
Level 2 |
Level 3 |
||||||
Financial Assets(1)
|
||||||||
Investments in equity securities . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
Investments in debt securities . . . . . . . . . . . . . . . . . . . . . . .
|
||||||||
Financial Liabilities(2)
|
||||||||
Contingent payment obligations . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
Affiliate equity purchase obligations . . . . . . . . . . . . . . . . . .
|
||||||||
For the Years Ended December 31, |
||||||||
2024 |
2025 |
|||||||
Contingent
Payment
Obligations
|
Affiliate
Equity Purchase
Obligations
|
Contingent
Payment
Obligations
|
Affiliate
Equity Purchase
Obligations
|
|||||
Balance, beginning of period . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
Purchases and issuances(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||||
Settlements and reductions . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||||
Net realized and unrealized (gains) losses(2) . . . . . . . . . . . . . .
|
( |
( |
( |
|||||
Balance, end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
Net change in unrealized (gains) losses relating to
instruments still held at the reporting date(1) . . . . . . . . . . . . . .
|
$( |
$ |
$( |
$ |
||||
Quantitative Information about Level 3 Fair Value Measurements |
||||||||||||||||
December 31, 2024 |
December 31, 2025 |
|||||||||||||||
Valuation
Techniques
|
Unobservable
Input
|
Fair Value |
Range |
Weighted
Average(1)
|
Fair Value |
Range |
Weighted
Average(1)
|
|||||||||
Contingent payment
obligations . . . . . . . . .
|
Monte Carlo
simulation
|
Volatility |
$ |
$ |
||||||||||||
Discount rates |
||||||||||||||||
Affiliate equity
purchase obligations . .
|
Discounted
cash flow
|
Growth rates(2)
|
$ |
( |
( |
$ |
( |
|||||||||
Discount rates |
||||||||||||||||
Monte Carlo
simulation
|
Volatility |
$ |
$ |
|||||||||||||
Discount rates |
||||||||||||||||
December 31, 2024 |
December 31, 2025 |
|||||||||
Carrying Value |
Fair Value |
Carrying Value |
Fair Value |
Fair Value
Hierarchy
|
||||||
Senior notes . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
Level 2 |
|||||
Junior subordinated notes . . . . . . . . . . . . . . .
|
Level 2 |
|||||||||
December 31, |
||||
2024 |
2025 |
|||
Senior bank debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Senior notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Junior subordinated notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Junior convertible securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
2030
Senior Notes
|
2034
Senior Notes
|
2036
Senior Notes
|
||||
Issue date . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
June 2020 |
August 2024 |
December 2025 |
|||
Maturity date . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
June 2030 |
August 2034 |
February 2036 |
|||
Par value (in millions) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Stated coupon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Coupon frequency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
Semi-annually |
Semi-annually |
Semi-annually |
|||
Effective interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
2059
Junior Subordinated
Notes
|
2060
Junior Subordinated
Notes
|
2061
Junior Subordinated
Notes
|
2064
Junior Subordinated
Notes
|
|||||
Issue date . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
March 2019 |
September 2020 |
July 2021 |
March 2024 |
||||
Maturity date . . . . . . . . . . . . . . . . . . . . . . . . .
|
March 2059 |
September 2060 |
September 2061 |
March 2064 |
||||
Par value (in millions) . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$ |
||||
Stated coupon . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||||
Coupon frequency . . . . . . . . . . . . . . . . . . . . .
|
Quarterly |
Quarterly |
Quarterly |
Quarterly |
||||
NYSE Symbol . . . . . . . . . . . . . . . . . . . . . . . .
|
MGR |
MGRB |
MGRD |
MGRE |
||||
Effective interest rate . . . . . . . . . . . . . . . . . . .
|
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Contractual interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Amortization of debt issuance costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Effective interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Goodwill |
||||
2024 |
2025 |
|||
Balance, beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||
Balance, end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Acquired Client Relationships (Net) |
||||||||||
Definite-lived |
Indefinite-lived |
Total |
||||||||
Gross Carrying
Value
|
Accumulated
Amortization
|
Net Carrying
Value
|
Carrying
Value
|
Carrying
Value
|
||||||
Balance, as of December 31, 2023 . . . . . . . .
|
$ |
$( |
$ |
$ |
$ |
|||||
Intangible amortization and impairments . .
|
— |
( |
( |
— |
( |
|||||
Foreign currency translation . . . . . . . . . . . .
|
( |
— |
( |
( |
||||||
Balance, as of December 31, 2024 . . . . . . . .
|
$ |
$( |
$ |
$ |
$ |
|||||
Intangible amortization and impairments . .
|
— |
( |
( |
( |
( |
|||||
Foreign currency translation . . . . . . . . . . . .
|
( |
— |
||||||||
Balance, as of December 31, 2025 . . . . . . . .
|
$ |
$( |
$ |
$ |
$ |
|||||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Revenue(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Net income(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
December 31, |
||||
2024 |
2025 |
|||
Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Liabilities and Non-controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Equity Method Investments in
Affiliates (Net)
|
||||
2024 |
2025 |
|||
Balance, beginning of period(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Investments in Affiliates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Affiliate transactions(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||
Earnings, net of tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Intangible amortization and impairments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Distributions of earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Return of capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Other(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||
Balance, end of period(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Operating lease costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Short-term lease costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Variable lease costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Sublease income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Total lease costs, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Operating
Leases
|
||
2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
|
2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||
2028 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||
2029 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||
2030 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||
Total undiscounted lease liabilities(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
December 31, |
||||
2024 |
2025 |
|||
Buildings and leasehold improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Furniture and fixtures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Land, improvements and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Fixed assets, at cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Accumulated depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Fixed assets (net) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
December 31, |
||||
2024 |
2025 |
|||
Accrued compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Other(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Payables and accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Redeemable Non-controlling
Interests
|
||||
2024 |
2025 |
|||
Balance, beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Increase attributable to consolidated Affiliate sponsored investment products . . . . . . . . . . . . .
|
||||
Transfers to Other liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Transfers from (to) Non-controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||
Changes in redemption value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Balance, end of period(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Controlling interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Non-controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Controlling
Interest
|
Remaining Life |
Non-controlling
Interests
|
Remaining Life |
|||||
2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||||||
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||||
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Net income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Decrease in controlling interest paid-in capital from Affiliate equity
issuances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Decrease in controlling interest paid-in capital from Affiliate equity
purchases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Net income (controlling interest) including the net impact of Affiliate equity
transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Shares
Repurchased
|
Average Price
Per Share
|
|||
2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
|||
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
Share-Based
Compensation
Expense
|
Tax Benefit |
|||
2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
Restricted
Stock Units
|
Weighted
Average
Grant Date
Value
Per Unit
|
|||
Unvested units, as of December 31, 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
|||
Units granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Units vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||
Units forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||
Performance condition changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Unvested units, as of December 31, 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
Stock
Options
|
Weighted
Average
Exercise Price
Per Option
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
||||
Unexercised options outstanding, as of December 31, 2024 . . . . . . . . . . . . . .
|
$ |
|||||
Options granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Options exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||
Options forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Options expired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||
Performance condition changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Unexercised options outstanding, as of December 31, 2025 . . . . . . . . . . . . . .
|
$ |
|||||
Exercisable at December 31, 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Controlling interest(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Non-controlling interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Income before income taxes (controlling interest) . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Effective tax rate (controlling interest)(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Current |
||||||
Federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Total current . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Deferred |
||||||
Federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Total deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Domestic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
International . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
U.S. federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
United Kingdom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
For the Years Ended December 31, |
||||||||||||
2023 |
2024 |
2025 |
||||||||||
$ |
% |
$ |
% |
$ |
% |
|||||||
Statutory U.S. federal tax . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||||||||
State income taxes, net of federal benefit(1) . .
|
||||||||||||
Foreign tax effects: |
||||||||||||
United Kingdom |
||||||||||||
Affiliate equity expense . . . . . . . . . . . . . . .
|
||||||||||||
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||||||||
Other foreign jurisdictions . . . . . . . . . . . . . .
|
( |
( |
( |
( |
( |
( |
||||||
Effect of cross-border tax laws . . . . . . . . . . . .
|
( |
( |
||||||||||
Nontaxable or nondeductible items . . . . . . . .
|
||||||||||||
Change in valuation allowance . . . . . . . . . . . .
|
||||||||||||
Unrecognized tax benefits . . . . . . . . . . . . . . .
|
||||||||||||
Other adjustments: |
||||||||||||
Effect of income from non-controlling
interests . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
( |
( |
( |
||||||
Effective tax . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||||||||
December 31, |
||||
2024 |
2025 |
|||
Deferred Tax Assets |
||||
State net operating loss carryforwards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
Foreign loss carryforwards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Foreign tax credits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Total deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Deferred tax assets, net of valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Deferred Tax Liabilities |
||||
Intangible asset amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Non-deductible intangible amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Junior convertible securities interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||
Deferred tax liability (net)(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$( |
$( |
||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Balance, beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Additions based on current year tax positions . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Additions based on prior years’ tax positions . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Reduction for prior years’ tax positions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||||
Lapse of the statute of limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
( |
|||
Settlements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||
Foreign currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||
Balance, end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Numerator |
||||||
Net income (controlling interest) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Income from hypothetical settlement of Redeemable non-controlling
interests, net of tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Interest expense on junior convertible securities, net of taxes . . . . . . . . . . . . .
|
||||||
Net income (controlling interest), as adjusted . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Denominator |
||||||
Average shares outstanding (basic) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Effect of dilutive instruments: |
||||||
Stock options and restricted stock units . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Hypothetical issuance of shares to settle Redeemable non-controlling
interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Assumed issuance of junior convertible securities shares . . . . . . . . . . . . . . .
|
||||||
Average shares outstanding (diluted) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Stock options and restricted stock units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Shares issuable to settle Redeemable non-controlling interests . . . . . . . . . . . .
|
||||||
For the Year Ended December 31, 2023 |
||||||
Pre-Tax |
Tax (Expense)
Benefit
|
Net of Tax |
||||
Foreign currency translation gain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$( |
$ |
|||
Change in net realized and unrealized gain (loss) on derivative financial
instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Change in net unrealized gain (loss) on available-for-sale debt securities . . . .
|
||||||
Other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$( |
$ |
|||
For the Year Ended December 31, 2024 |
||||||
Pre-Tax |
Tax Expense |
Net of Tax |
||||
Foreign currency translation gain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$( |
$ |
|||
Change in net realized and unrealized gain (loss) on derivative financial
instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Change in net unrealized gain (loss) on available-for-sale debt securities . . . .
|
( |
|||||
Other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$( |
$ |
|||
For the Year Ended December 31, 2025 |
||||||
Pre-Tax |
Tax Benefit |
Net of Tax |
||||
Foreign currency translation gain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Change in net realized and unrealized gain (loss) on derivative financial
instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||||
Change in net unrealized gain (loss) on available-for-sale debt securities . . . .
|
||||||
Other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
Foreign
Currency
Translation
Adjustment
|
Realized and
Unrealized
Gain (Loss) on
Derivative
Financial
Instruments
|
Unrealized
Gain (Loss)
on
Available-
for-Sale
Debt
Securities
|
Total |
|||||
Balance, as of December 31, 2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$( |
$( |
$( |
$( |
||||
Other comprehensive income (loss) before reclassifications . . . . . . . . . .
|
( |
|||||||
Amounts reclassified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||||
Net other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||||
Balance, as of December 31, 2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$( |
$ |
$( |
$( |
||||
Other comprehensive income (loss) before reclassifications . . . . . . . . . .
|
( |
|||||||
Amounts reclassified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
( |
||||||
Net other comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||||
Balance, as of December 31, 2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$( |
$( |
$ |
$( |
For the Years Ended December 31, |
||||||
2023 |
2024 |
2025 |
||||
Consolidated revenue |
||||||
United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
United Kingdom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||||
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
|||
December 31, |
||||
2024 |
2025 |
|||
Fixed assets (net) |
||||
United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
United Kingdom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
||||
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
||
(in millions) |
Balance
Beginning of
Period
|
Additions
Charged to Costs
and Expenses
|
Additions
Charged to
Other Accounts
|
Deductions |
Balance
End of Period
|
|||||
Income Tax Valuation Allowance |
||||||||||
Years Ending December 31, |
||||||||||
2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$( |
$ |
|||||
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||||||
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||||||
Other Allowances(1)
|
||||||||||
Years Ending December 31, |
||||||||||
2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
$ |
$ |
$ |
$( |
$ |
|||||
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
|||||||||
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
( |
Page No. |
||
Schedule II - Valuation and Qualifying Accounts for the years ended December 31, 2023, 2024, and
2025
|
3.1 |
|
3.2 |
|
3.3 |
|
3.4 |
|
3.5 |
|
4.1 |
|
4.2 |
|
4.3 |
|
4.4 |
|
4.5 |
|
4.6 |
|
4.7 |
|
4.8 |
|
4.9 |
|
4.10 |
|
10.1† |
|
10.2† |
|
10.3† |
|
10.4† |
|
10.5† |
10.6† |
|
10.7† |
|
10.8† |
|
10.9† |
|
10.10† |
|
10.11† |
|
10.12† |
|
10.13† |
|
10.14† |
|
10.15† |
|
10.16† |
|
10.17† |
|
10.18† |
|
10.19† |
|
10.20† |
|
10.21 |
|
10.22 |
|
10.23 |
|
19 |
|
21 |
|
23 |
|
31.1 |
|
31.2 |
|
32.1 |
|
32.2 |
|
97 |
101 |
The following financial statements from the Registrant’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2025 are filed herewith, formatted in XBRL (Inline eXtensible Business Reporting Language): (i) the
Consolidated Statements of Income for the years ended December 31, 2025, 2024, and 2023, (ii) the Consolidated
Balance Sheets as of December 31, 2025 and December 31, 2024, (iii) the Consolidated Statement of Equity for the
years ended December 31, 2025, 2024, and 2023, (iv) the Consolidated Statements of Cash Flows for the years
ended December 31, 2025, 2024, and 2023, and (v) the Notes to the Consolidated Financial Statements
|
104 |
The cover page from the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025,
formatted in XBRL (Inline eXtensible Business Reporting Language) and contained in Exhibit 101
|
AFFILIATED MANAGERS GROUP, INC.
(Registrant)
|
||||
Date: February 17, 2026 |
By: |
/s/ JAY C. HORGEN |
||
Jay C. Horgen
Chief Executive Officer
|
Signature |
Title |
Date |
||
/s/ JAY C. HORGEN |
Chief Executive Officer
(Principal Executive Officer) and
Director
|
February 17, 2026 |
||
Jay C. Horgen |
||||
/s/ DAVA E. RITCHEA |
Chief Financial Officer
(Principal Financial and Principal
Accounting Officer)
|
February 17, 2026 |
||
Dava E. Ritchea |
||||
/s/ KAREN L. ALVINGHAM |
Director |
February 17, 2026 |
||
Karen L. Alvingham |
||||
/s/ MARCY ENGEL |
Director |
February 17, 2026 |
||
Marcy Engel |
||||
/s/ ANNETTE FRANQUI |
Director |
February 17, 2026 |
||
Annette Franqui |
||||
/s/ FÉLIX V. MATOS RODRÍGUEZ |
Director |
February 17, 2026 |
||
Félix V. Matos Rodríguez |
||||
/s/ TRACY P. PALANDJIAN |
Director |
February 17, 2026 |
||
Tracy P. Palandjian |
||||
/s/ DAVID C. RYAN |
Director |
February 17, 2026 |
||
David C. Ryan |
||||
/s/ LOREN M. STARR |
Director |
February 17, 2026 |
||
Loren M. Starr |
||||
| /s/ JAY C. HORGEN | ||||||||
|
Jay C. Horgen
Chief Executive Officer
|
||||||||
| /s/ DAVA E. RITCHEA | ||||||||
|
Dava E. Ritchea
Chief Financial Officer
|
||||||||
| /s/ JAY C. HORGEN | ||||||||
|
Jay C. Horgen
Chief Executive Officer
|
||||||||
| /s/ DAVA E. RITCHEA | ||||||||
|
Dava E. Ritchea
Chief Financial Officer
|
||||||||